Evidence map›Paper›PMID 34912503›Full record

ArticleInfection ecology & epidemiology2022

Low 30-day mortality and low carbapenem-resistance in a decade of

Erik Ingefors, Jonas Tverring, Fatima Nafaa, Niklas Jönsson, Sara Karlsson Söbirk, Charlott Kjölvmark, Oskar Ljungquist

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection ecology & epidemiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Erik IngeforsDepartment of Infectious Diseases, Helsingborg Hospital, Helsingborg, Sweden.ORCID https://orcid.org/0000-0003-4901-2224
Jonas TverringDepartment of Infectious Diseases, Helsingborg Hospital, Helsingborg, Sweden.
Fatima NafaaClinical Microbiology, Infection Prevention and Control, Region Skåne, Lund, Sweden.
Niklas JönssonClinical Microbiology, Infection Prevention and Control, Region Skåne, Lund, Sweden.
Sara Karlsson SöbirkDivision of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden.ORCID https://orcid.org/0000-0002-3789-0532
Charlott KjölvmarkDepartment of Infectious Diseases, Helsingborg Hospital, Helsingborg, Sweden.
Oskar LjungquistDepartment of Infectious Diseases, Helsingborg Hospital, Helsingborg, Sweden.ORCID https://orcid.org/0000-0003-2951-1309
Lund University · SEHelsingborgs lasarett · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to provide a descriptive account of carbapenem resistance and risk factors for mortality from invasive

methodsBlood isolates with growth of

resultsThere were 179 bacteraemia episodes in 176 patients included in the study. The 30-day all-cause mortality was 16%. In all, two percent of

conclusionThis study on

Indexed as

Antimicrobial resistanceblood stream infectionsMALDI-TOFnosocomial infectionopportunistic infections

Identifiers

PMID34912503
PMCPMC8667949
OpenAlexW4200060683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.